Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug

Published on 18 Nov 2024 on Pharma Voice · via Yahoo Finance

Merck & Co.’s recent $1.3 billion deal to reel in Modifi Biosciences seemed to ignore pharma’s...

Read the rest of the article

Start tracking your investments with Statfolio

Columbia Threadneedle Investments, an investment management company released its “Columbia Divide...

Insider Monkey · via Yahoo Finance 26 Nov 2024

Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair...

TipRanks · via Yahoo Finance 26 Nov 2024

Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder cau...

Reuters · via Yahoo News 25 Nov 2024

On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evalu...

Benzinga · via Yahoo Finance 25 Nov 2024

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 25 Nov 2024

We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest...

Insider Monkey · via Yahoo Finance 22 Nov 2024

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks ...

Zacks · via Yahoo Finance 22 Nov 2024

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you mig...

Zacks · via Yahoo Finance 22 Nov 2024

U.S. government researchers have found that a widely prescribed asthma drug originally sold by Me...

Reuters · via Yahoo Finance 22 Nov 2024